DEFENSE TECHNOLOGY OBJECTIVES
COUNTERPROLIFERATION,
COUNTERFORCE
| Svc/Agency POC: | USD(A&T)POC: | Customer POC: |
|
Maj. Mark Seymour DASG-RDZ (703)695-8443 |
Curt Gladden US Army Chemical School DSN 865-6572 LTC Jim Hansen JPO-BD (703)681-3468 |
Col. Gary Husrt, M.D. ODATSD(CBM) (703)602-5620 FAX:(703)602-5742 hurst@acq.osd.mil |
Programmed DTO Funding ($M):
| Program Element/Project | ||||||
| 0602787A/TB2 | ||||||
| 0603002A/TB3 | ||||||
L.02. Medical Chemical Defense. Develop, demonstrate, and field new prophylactic measures, drugs, and diagnostic kits for prevention, treatment, and diagnosis of chemical warfare agents. This DTO will protect forces from the consequences of exposure to chemical agents and force survivability and mission accomplishment. Fulfilling this DTO will be achieved by accomplishing several objectives. By FY00, conduct a Milestone 0 transition of an vesicant agent countermeasures. By FY99, conduct a Milestone 0 transition of a reactive topical skin protectant against nerve and vesicant agents. By FY99, conduct a Milestone 0 transition of a reactive/catalytic nerve agent prophylaxes.
| Svc/Agency POC: | USD(A&T)POC: | Customer POC: |
|
Maj. Mark Seymour DASG-RDZ (703)695-8443 |
Curt Gladden US Army Chemical School DSN 865-6572 LTC Jim Hansen JPO-BD (703)681-3468 |
Col. Gary Husrt, M.D. ODATSD(CBM) (703)602-5620 FAX:(703)602-5742 hurst@acq.osd.mil |
Programmed DTO Funding ($M):
| Program Element/Project | ||||||
| 0602787A/TC2 | ||||||
| 0603002A/TC3 | ||||||
L.03. Counterproliferation I ACTD (Technologies to Defeat Shallow-Buried Biological and Chemical Weapon Storage and Production Facilities). Develop and demonstrate technologies to effectively target and defeat chemical and biological production facilities that are shallow-buried or bermed, above-ground targets while minimizing collateral damage. This technology development is for demonstration in Phases I and II of the Counterproliferation/ Counterforce ACTD. Technologies being developed fall into three categories: weapons, sensors, and planning/targeting tools. In Phase I of the ACTD, to be completed in FY96, the application of current warhead technology augmented with a programmable, void-sensing/DOB-sensing Hard-Target Smart Fuse (HTSF), being developed by Wright Lab, will be demonstrated. Planning tools for targeting (MEA) and collateral effects prediction (HPAC), being developed by DNA, will also be demonstrated. In Phase II, to be completed in FY98, these Phase I technologies will be supplemented by the following technologies. The Advanced Unitary Penetrator (AUP), being developed by Wright Lab, will provide the penetration capability of the BLU-113 in a BLU-109-class bomb. The Inertial, Terrain-Aided Guidance (ITAG) system, being developed by Sandia Lab, will provide reduced CEP over current systems employing the BLU-109 while providing adverse-weather capability. The Weapon-Borne Sensor (WBS), being developed by Wright Lab, will provide the acceleration history of the penetrator to provide target characterization and BDA. Unattended Ground Sensors (UGS), being developed by Sandia Labs and LLNL, will provide characterization and location of critical equipment for targeting and BDA. And a modified FLIR, being developed by DNA, will measure plume signatures for BDA. The planning tools MEA and HPAC will be integrated to provide increased utility for targeting and collateral-effects prediction in Phase II. They will also be upgraded to provide more accurate predictions for hardened, buried structures.
| Svc/Agency POC: | USD(A&T)POC: | Customer POC: |
|
Mr. Vayl S. Oxford DNA/PMC (703)325-2043 |
Col. Tom Wallace EUCOM DSN 580-8304 |
Col.Ellen Pawlikowski ATSD (NCB) (CP) (703)693-9410 pawlikem@acq.osd.mil |
Programmed DTO Funding ($M):
| Program Element/Project | ||||||
| 0603160D/P6539 | ||||||
| 0602160D/P6533 | ||||||
| 0605160D/P6542 | ||||||
| 0603750D/P6523 | ||||||
| PE62715H/AB | ||||||
| DUSD (AT&T) | ||||||
L.04. Counterproliferation II ACTD (Technologies to Defeat an Expanded WMD Target Set including Surface, Mobile, and Deeply Buried Targets). Develop and demonstrate technologies to defeat a broad range of WMD targets while minimizing collateral damage. The targets are divided into three categories corresponding to Phases III through V of the Counterproliferation/ Counterforce ACTD. The first set includes mobile BW/CW missiles in the open (stationary) and in shelters (tunnels) and above ground BW/CW production facilities. The second includes nuclear production facilities, such as reactors and separation facilities, and associated hardened, shallow-buried C3I facilities. The third includes deeply buried tunnels containing chemical and biological weapon production facilities and associated C3I facilities. In the case of the deeply buried targets, the objective is functional kill of the target. Technologies being developed fall into three categories: weapons, sensors, and planning/targeting tools. The new weapon technologies include enhanced payloads (incendiary and agent-defeat technologies) and an advanced warhead for defeating mobile missiles without producing collateral effects by destroying the BW/CW warheads. It also includes advanced penetrators such as the boosted penetrator to attack very hard targets and a miniature penetrator for precision strike against a nuclear facility (to force controlled shut-down). Improved precision guidance will also be developed for an improved precision strike capability. In the sensor area, advanced characterization and BDA sensors will be developed including chem, bio, nuclear, and electromagnetic UGS, 3D seismic/acoustic UGS, and void detection sensors such as gravimeters and magnetometers. Remote collateral effects sensors will also be developed. Sensors will be air-delivered, SOF-delivered, and on UAV platforms. DNAs targeting and collateral effects tools, MEA and HPAC, will be upgraded to provide predictions of the effects of the new munitions in the expanded target set and to provide new targeting methodologies for attacking this broader target set. This new technology will be developed during FY97-04 and will be demonstrated in Phase III of the CP ACTD in FY2000, in Phase IV in FY02, and in Phase V in FY04. Note that the CP II ACTD will not demønstrate a complete solution to the general problem of finding mobile missile launchers or buried WMD targets.
| Svc/Agency POC: | USD(A&T)POC: | Customer POC: |
|
Mr. Vayl S. Oxford DNA/PMC (703)325-2043 |
Col. Tom Wallace EUCOM DSN 580-8304 |
Col.Ellen Pawlikowski ATSD (NCB) (CP) (703)693-9410 pawlikem@acq.osd.mil |
Programmed DTO Funding ($M):
| Program Element/Project | ||||||
| 0603160D/P6539 | ||||||